IFNA1 and hepatocellular carcinoma: As for the patient who developed HCC, irrespective of IFN re-treatment, it may be assumed that since the patient developed HCC within 18 months of IFN treatment, perhaps there was a pre-existing HCC, prior to IFN therapy for which HCC could not be prevented even with additional IFN.